Schnitzel lover
Regular
Growth company metrics and Market Cap..
NEU MC $3.2bill HY revenue $63mil/ profit 47mill
PME MC $10bill HY revenue $68 mill/ profit 33 mill
AD8 MC $1.3bill HY revenue $38mill/ profit 11mill
So BRN at MC $297mill on undetermined revenue or new IP status..
Likely gets to $1.5bill-2bill MC on first $5-10mill in revenue, and that would double or more if the my do $20mill plus as long as profits are showing..
Ie. If BRN did $40mill rev and posted a 20mill profit, the market would most likely price BRN at similar metrics to PME..
In my view..
Down here at $300mill MC for me suggests (in my view) that I’m not expecting any revenue in the $5mill plus category before 2024 H1 report.
NDAs are BRNs only real defence to tangible performance or lack therof IMO..
Ie. If these customers don’t want to be publicly named until their Akida based products are in the market, then the Valeos, Renesas’, Megachips & their sub-licensees are likely the only companies that can be in products short-medium term.
I just can’t see how BRN share price could possibly be this low if the above paragraph customers had products coming to the market imminently..
There would have to be some insider and tech market knowledge to force more buying over selling, assuming the top paragraph MC valuations of revenue producing high growth companies..
NEU MC $3.2bill HY revenue $63mil/ profit 47mill
PME MC $10bill HY revenue $68 mill/ profit 33 mill
AD8 MC $1.3bill HY revenue $38mill/ profit 11mill
So BRN at MC $297mill on undetermined revenue or new IP status..
Likely gets to $1.5bill-2bill MC on first $5-10mill in revenue, and that would double or more if the my do $20mill plus as long as profits are showing..
Ie. If BRN did $40mill rev and posted a 20mill profit, the market would most likely price BRN at similar metrics to PME..
In my view..
Down here at $300mill MC for me suggests (in my view) that I’m not expecting any revenue in the $5mill plus category before 2024 H1 report.
NDAs are BRNs only real defence to tangible performance or lack therof IMO..
Ie. If these customers don’t want to be publicly named until their Akida based products are in the market, then the Valeos, Renesas’, Megachips & their sub-licensees are likely the only companies that can be in products short-medium term.
I just can’t see how BRN share price could possibly be this low if the above paragraph customers had products coming to the market imminently..
There would have to be some insider and tech market knowledge to force more buying over selling, assuming the top paragraph MC valuations of revenue producing high growth companies..